Parc Elisabeth Pharma SRL
Parc Elisabeth Pharma reported revenue of 491,912 € for the 2025 financial year (annual accounts filed with the NBB on 04 Mar 2026).
The score of Parc Elisabeth Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -34 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Parc Elisabeth Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 491,912 € | ||||
| Net result | −12,285 € | ||||
| Equity | −63,400 € | ||||
| Cash | 78 € | ||||
| EBITDA | 40,726 € | ||||
| Total assets | 296,304 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Mar 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
Parc Elisabeth Pharma's financial analysis
- Solvency-21.4%sector median: 41.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Parc Elisabeth Pharma
Parc Elisabeth Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0578.934.701
- VAT number
- BE0578934701
- Peppol
- Registered · 0208:0578934701 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Jan 2015
- Registered office
- 1083 Ganshoren
- Latest accounts
- 2025 · filed on 04 Mar 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Parc Elisabeth Pharma (SRL) has been based in Ganshoren since 2015, active in: manufacture of medicaments. For 2025, it reports revenue of 491,912 €, a net loss of 12,285 € and equity of −63,400 €. Its solvency stands at -21.4%, below the median of its sector (41.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Parc Elisabeth Pharma
Companies in the same business, of comparable size and area, outside its group.
- LBS Manufacture of pharmaceutical preparations Ghent · balance sheet 291,800 €
- Mountvector Bio Manufacture of pharmaceutical preparations Ottignies-Louvain-la-Neuve · balance sheet 180,416 €
- Unda Manufacture of pharmaceutical preparations Aywaille · balance sheet 517,605 €
- 272BIO Manufacture of pharmaceutical preparations Ghent · balance sheet 709,601 €
- Phenix Property Manufacture of pharmaceutical preparations Hoogstraten · balance sheet €1.13m
- Pledge Therapeutics Manufacture of basic pharmaceutical products Leuven · balance sheet 229,854 €
- Eurandlab Manufacture of pharmaceutical preparations Charleroi · balance sheet 27,845 €
- Dr. Lins - Dr. Dubois Manufacture of basic pharmaceutical products Antwerp · balance sheet 699,515 €
Frequently asked questions about Parc Elisabeth Pharma
What is the revenue of Parc Elisabeth Pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of Parc Elisabeth Pharma amounts to 491,912 €.
What is the VAT number of Parc Elisabeth Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0578934701 for Parc Elisabeth Pharma, if the company is VAT-registered. Its company number (CBE) is 0578.934.701.
Where is the registered office of Parc Elisabeth Pharma?
According to the CBE register, the registered office of Parc Elisabeth Pharma is in 1083 Ganshoren.
What is the equity of Parc Elisabeth Pharma?
At the close of the 2025 financial year, the equity of Parc Elisabeth Pharma amounts to -63,400 €, a solvency of -21.4% of total assets.
Who manages Parc Elisabeth Pharma?
The register lists 1 active mandates at Parc Elisabeth Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Parc Elisabeth Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →